Early Detection of Anthracycline-Induced Cardiotoxicity in Breast Cancer Survivors With T2 Cardiac Magnetic Resonance
Authors:
- 1 May 2019
- journal article
- letter
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 12 (5) , e008777
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Progressive 3-Month Increase in LV Myocardial ECV After Anthracycline-Based ChemotherapyJACC: Cardiovascular Imaging, 2017
- Characterization of the Changes in Cardiac Structure and Function in Mice Treated With Anthracyclines Using Serial Cardiac Magnetic Resonance ImagingCirculation: Cardiovascular Imaging, 2016
- Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: Effects on left ventricular ejection fraction, troponin I and brain natriuretic peptideInternational Journal of Cardiology, 2011
- Anthracycline Cardiomyopathy Is Mediated by Depletion of the Cardiac Stem Cell Pool and Is Rescued by Restoration of Progenitor Cell FunctionCirculation, 2010
- Stem Cell Therapy with Overexpressed VEGF and PDGF Genes Improves Cardiac Function in a Rat Infarct ModelPLOS ONE, 2009